CD36 and diabetic cardiomyopathy: In addition, Xu et al. (110) also found miR-200b-3p expression was significantly reduced in diabetic cardiomyopathy tissues and cells, which could target CD36 directly to reduce cardiomyocytes apoptosis in diabetic cardiomyopathy.